[68] reported that RUNX1 expression levels in DS-iPSCs were significantly higher than in controls and correlated with impaired mitochondrial functions and increased apoptosis, while inhibition of RUNX1 expression improved the mitochondrial function in DS-iPSCs. This evidence concerns the gene RUNX1 and Dravet syndrome.